Sai Life Sciences (SAILIFE) | Stock Overview & Key Data
Sai Life Sciences Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹1,244.20 on June 12, 2026
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sai Life Sciences
SAILIFE
|
217.06B Large-cap | 1.11% | 10.73% | 23.70% | 32.85% | 34.17% | 58.19% | 73.11% | 73.11% | 73.11% | 73.11% | 73.11% |
|
Dr. Lal PathLabs
LALPATHLAB
|
238.92B Large-cap | 4.53% | 0.82% | 20.51% | 13.04% | 7.03% | 8.45% | 58.06% | 0.84% | 257.00% | 257.46% | 257.46% |
|
Syngene
SYNGENE
|
169.26B Mid-cap | 0.89% | -0.12% | 10.57% | -31.32% | -30.25% | -29.79% | -38.23% | -19.99% | 131.38% | 186.56% | 186.56% |
|
Vijaya Diagnostic
VIJAYA
|
109.64B Mid-cap | -1.87% | -3.46% | 36.74% | 29.74% | 23.10% | 35.44% | 216.81% | 105.30% | 105.30% | 105.30% | 105.30% |
|
Metropolis
METROPOLIS
|
97.90B Mid-cap | -0.71% | -0.56% | 14.36% | 9.60% | 10.90% | 24.89% | 56.99% | -23.14% | 118.75% | 118.75% | 118.75% |
|
Thyrocare
THYROCARE
|
62.88B Mid-cap | -1.06% | 15.89% | 48.78% | 23.90% | 19.90% | 55.33% | 231.85% | 23.21% | 170.47% | 153.71% | 153.71% |
Ownership & Short Interest
Calculate Your Sai Life Sciences Investment Returns
Long-Term Investment Performance Analysis
Sai Life Sciences stock price in Dec 2024 was ₹703.65, A ₹1,000.00 lump sum investment in Sai Life Sciences made 1 years ago would be worth approximately ₹1,716.62 today, representing a solid return of 71.66%. This translates to an annualized return (CAGR) of 43.54%.
1 Year 5 Months Investment Scenario (Dec 2024 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is SAILIFE's 52-week high and low?
- In the last 52 weeks, Sai Life Sciences reached a high of ₹1,244.20 (on June 12, 2026) and a low of ₹716.60 (on June 19, 2025).
- What is the market cap and P/E ratio for SAILIFE?
- Curious about Sai Life Sciences's size and valuation? Its market capitalization stands at 217.06B. When it comes to valuation, the P/E ratio (trailing twelve months) is 64.75, and the forward P/E (looking ahead) is 51.15.
- Does SAILIFE pay dividends? If so, what's the yield?
- As for dividends, Sai Life Sciences isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Sai Life Sciences's main competitors or similar companies to consider before investing?
When looking at Sai Life Sciences, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Dr. Lal PathLabs
LALPATHLAB238.92B Healthcare Diagnostics & Research 8.45% 58.06% Syngene
SYNGENE169.26B Healthcare Diagnostics & Research -29.79% -38.23% Vijaya Diagnostic
VIJAYA109.64B Healthcare Diagnostics & Research 35.44% 216.81% Metropolis
METROPOLIS97.90B Healthcare Diagnostics & Research 24.89% 56.99% Thyrocare
THYROCARE62.88B Healthcare Diagnostics & Research 55.33% 231.85% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Sai Life Sciences Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Sai Life Sciences's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 7.99%, the Debt to Equity ratio from the most recent quarter is 18.40, and its Gross Profit Margin stands at 45.92%.
- What is the recent revenue and earnings growth for SAILIFE?
- Looking at Sai Life Sciences's growth, its revenue over the trailing twelve months (TTM) was INR22B. Compared to the same quarter last year (YoY), quarterly revenue grew by 26.50%, and quarterly earnings saw a YoY growth of 86.40%.
- How much of SAILIFE stock is held by insiders and institutions?
- Wondering who owns Sai Life Sciences stock? Company insiders (like executives and directors) hold about 38.09% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 44.22%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.